What happened
Reyon Pharmaceutical disclosed convertible bonds to raise US$8.19M, about 5.9% of its market value.
For context, this raise equals about 5.9% of the company's market value, which is the rough scale of potential new-share dilution.
| Instrument | Convertible bonds |
|---|---|
| Raise amount | US$8.19M |
| vs. market value | 5.9% |
| Filed | 2026-10-08, Material event report (convertible bonds) |
| Source | DART rcept 20261008000687 → open original filing |
Source: DART. Information only, not investment advice.